Page last updated: 2024-09-04

moxifloxacin and aprepitant

moxifloxacin has been researched along with aprepitant in 4 studies

Compound Research Comparison

Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010)
(moxifloxacin)
Studies
(aprepitant)
Trials
(aprepitant)
Recent Studies (post-2010) (aprepitant)
3,1575521,690769229521

Protein Interaction Comparison

ProteinTaxonomymoxifloxacin (IC50)aprepitant (IC50)
Cytochrome P450 3A4Homo sapiens (human)0.046
Substance-P receptorHomo sapiens (human)0.0002
Substance-P receptorMeriones unguiculatus (Mongolian gerbil)0.0001

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Constanzer, ML; Dru, J; Evans, JK; Han, TH; Jin, B; Marbury, TC; Murphy, MG; Panebianco, D; Shadle, CR; Sun, H1

Reviews

1 review(s) available for moxifloxacin and aprepitant

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for moxifloxacin and aprepitant

ArticleYear
Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
    Anesthesia and analgesia, 2009, Volume: 109, Issue:2

    Topics: Adolescent; Adult; Anti-Infective Agents; Antidepressive Agents; Aprepitant; Aza Compounds; Cross-Over Studies; Double-Blind Method; Electrocardiography; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Heart Rate; Humans; Linear Models; Male; Middle Aged; Morpholines; Moxifloxacin; Prodrugs; Quinolines; Young Adult

2009

Other Studies

2 other study(ies) available for moxifloxacin and aprepitant

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008